About Scleroderma

Overview

Scleroderma, also known as systemic sclerosis, is a chronic autoimmune connective tissue disease that causes inflammation and abnormal growth of connective tissue in various parts of the body. It primarily affects the skin, leading to patches of tight and hard skin. However, scleroderma can also damage other organs such as the lungs, heart, kidneys, digestive tract, muscles, and joints. There are two major types of scleroderma:

• Localized scleroderma: This type only affects the skin and the structures directly beneath
• Systemic scleroderma: This is the more serious form that affects multiple systems in the body, including blood vessels and internal organs like the heart, lungs, and kidneys

The exact cause of scleroderma is not fully understood, but it is believed to involve abnormalities in the immune system. Scientists have identified certain immune proteins called autoantibodies and abnormal accumulations of T cells in the skin and other tissues of individuals with scleroderma. However, more research is needed to fully understand the underlying mechanisms of this condition.

Causes and Risk Factors

Scleroderma is an autoimmune disease that involves multiple systems in the body. The disease causes of scleroderma include:

• Vascular injury: This damages the blood vessels, leading to the release of chemicals that cause the blood vessels to tighten. This can also lead to a lack of oxygen in the tissues.
• Immunogenicity: This means the body's immune system starts to create antibodies, which are proteins that attack the body’s own tissues.
• Fibroblast dysfunction: Fibroblasts are cells that help build tissues. When they don't work properly, too much of a substance called "extracellular matrix" builds up in the tissues, leading to scarring.

The non-modifiable risk factors for scleroderma cannot be controlled or changed. They include:

• Age: Increasing age is a risk factor for developing scleroderma.
• Genetic predispositions: A positive family history of scleroderma or related autoimmune diseases can increase the risk.
• Sex: Females are more likely to develop scleroderma than males.

The modifiable risk factors for scleroderma are not well-established. However, certain lifestyle factors may influence the disease's progression and severity. These modifiable risk factors may include:

• Smoking: Smoking has been suggested as a potential risk factor for developing scleroderma, but further research is needed to establish a definitive link.
• Environmental exposures: Exposure to certain chemicals or toxins may contribute to the development of scleroderma, but more research is needed to understand this relationship fully.

It's important to note that while these factors may be associated with an increased risk of developing scleroderma, they do not guarantee that an individual will develop the condition. Additionally, the exact cause of scleroderma is still unknown, and further research is needed to fully understand its pathophysiology and risk factors.

Symptoms

Common early symptoms of scleroderma include:

• Pain, stiffness, swelling, and tightness in the fingers, hands, or feet
• Sensitivity to cold or emotional stress
• Swollen hands and fingers in the morning
• Swelling and puffiness in the fingers and toes
• Itching

As scleroderma progresses or reaches higher severity, other symptoms may occur:

• Skin thickening and hardening
• Limited mobility in the hands and fingers
• Curled inward fingers (sclerodactyly)
• Difficulty swallowing or keeping food down
• Heartburn and abdominal pain
• Shortness of breath and dry cough
• Chest pain, abnormal heart rhythms, and heart failure
• Kidney damage leading to high blood pressure and decreased urine production
• Dry eyes and mouth
• Facial pain (trigeminal neuralgia)
• Impotence
• Ulcers over joints due to stretching of tight skin with bending
• Changes in skin pigment

It is important to note that the symptoms and severity of scleroderma can vary from person to person. If you are experiencing any of these symptoms, it is recommended to consult with a healthcare professional for an accurate diagnosis and appropriate management.

Diagnosis

To diagnose scleroderma, doctors typically use a combination of examinations, tests, and procedures. Here are the common ones:

• Physical examination: The doctor will look for signs like skin thickening, joint stiffness, or other symptoms that could point to scleroderma.
• Blood tests: These can check for specific antibodies in the blood that are often present in people with scleroderma. The tests can help confirm the diagnosis and determine which type of scleroderma a person may have.
• Imaging tests: X-rays, CT scans, or ultrasounds might be used to examine internal organs, like the lungs or heart, to see if they're affected by the disease.
• Skin biopsy: In some cases, the doctor might take a small sample of skin to examine under a microscope to look for changes typical of scleroderma.
• Pulmonary function tests: These tests check how well the lungs are working since scleroderma can sometimes cause lung problems.

It's important to note that the specific examinations and tests recommended may vary depending on your symptoms and individual case. Your healthcare provider will determine which tests are appropriate for you. If you have any concerns or questions about the diagnostic process, it's best to consult with your doctor.

Treatment Options

The goals of treatment for scleroderma are to relieve symptoms, prevent the condition from worsening, manage complications, and improve overall quality of life. Here are the recommended treatments and how they work to achieve these goals:

Medications:

• Anti-inflammatory medications: Help manage pain and reduce swelling.
• Corticosteroid topical creams: Treat skin changes, including tightness and itching.
• Corticosteroids (oral, injection, or IV): Manage joint pain or inflammation. These are generally avoided because they have been associated with kidney problems in patients with systemic scleroderma.
• Immunosuppressants: Suppress the overactive immune system and control disease symptoms.
• Vasodilators: Dilate blood vessels to prevent lung and kidney damage and treat Raynaud's phenomenon.
• Calcium channel blockers and bisphosphonates: Treat calcium deposition problems.

Therapies and Therapeutic Procedures:

• Physical therapy: Relieves pain, improves muscle strength, and enhances mobility.
• Occupational therapy: Recommends devices to aid with daily activities like brushing teeth.
• Ultraviolet light therapy and laser surgery: Improve skin condition and appearance.
• Hyaluronidase injections: Treat microstomia, which affects mouth opening.

Self-care and health behavior changes:

• Regular dental care: Prevent tooth decay and maintain oral health.
• Self-management programs: Increase self-efficacy for disease management and improve quality of life.

These treatments aim to control symptoms, limit damage, manage complications, improve mobility, and enhance overall well-being. Remember to consult your healthcare professional for personalized advice.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.